This week a California jury said Bayer needs to pay 70-year-old Edwin Hardeman $80 million for its liability in his Non-Hodgkin Lymphoma diagnosis. This includes $200,000 in past medical expenses, $5.6 million in compensatory damages and $75 million in punitive damages, reports Agri-Pulse.
This is the second time this year a jury has found Monsanto, now Bayer, liable for cancer. The plaintiff said he used Roundup for 26 years and was diagnosed with Non-Hodgkin lymphoma.. This jury said the company failed to warn users, was negligent, and had design defects in Roundup.
The first jury awarded Dewayne Johnson $289 million, which was later reduced to $78 million. Bayer is appealing the first verdict. Dewayne Johnson worked for a public-school system in California for two years when he was diagnosed with non-Hodgkin’s lymphoma. During his tenure with the school he used Roundup and other herbicides extensively for landscaping.
In terms of this week’s verdict, the plaintiffs consider it a huge success.
“Today, the jury resoundingly held Monsanto accountable for its 40 years of corporate malfeasance and sent a message to Monsanto that it needs to change the way it does business,” Hardeman attorney Aimee Wagstaff said in a statement to Agri-Pulse.
Bayer says it will appeal this verdict in a statement provided to Agweb:
“We are disappointed with the jury’s decision, but this verdict does not change the weight of over four decades of extensive science and the conclusions of regulators worldwide that support the safety of our glyphosate-based herbicides and that they are not carcinogenic. The verdict in this trial has no impact on future cases and trials, as each one has its own factual and legal circumstances. Bayer will appeal this verdict.“
In addition, Bayer faces more than 11,200 additional plaintiffs alleging the herbicide causes Non-Hodgkin’s lymphoma. Six more trials will start in state and federal courts this year, according to Dow Jones